GHRP-2 Protects the Liver From Endotoxin-Induced Inflammation
GHRP-2 prevented liver inflammatory responses to endotoxin (LPS) in rats, reducing hepatic TNF-α, IL-1β, and NF-κB activation — demonstrating GH secretagogue liver protection through anti-inflammatory mechanisms.
Quick Facts
What This Study Found
GHRP-2 administration prevented endotoxin-induced liver inflammation in rats: reduced hepatic TNF-α, IL-1β, IL-6, and NF-κB activation — demonstrating direct anti-inflammatory hepatoprotection by GH secretagogues independent of GH release.
Key Numbers
How They Did This
animal-study study.
Why This Research Matters
Relevant for ghrp, inflammation, liver.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding GHRP-2 administration prevented endotoxin-induced liver inflammation in rats: reduced hepatic TNF-α, IL-1β, IL-6, and NF-κB activation — demonstrating
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2008.
- Original Title:
- GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.
- Published In:
- American journal of physiology. Endocrinology and metabolism, 294(1), E131-41 (2008)
- Authors:
- Granado, Miriam(4), Martín, Ana Isabel, López-Menduiña, María, López-Calderón, Asunción, Villanúa, M Angeles
- Database ID:
- RPEP-01344
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What was studied?
GHRP-2 Protects the Liver From Endotoxin-Induced Inflammation
What was found?
GHRP-2 prevented liver inflammatory responses to endotoxin (LPS) in rats, reducing hepatic TNF-α, IL-1β, and NF-κB activation — demonstrating GH secretagogue liver protection through anti-inflammatory mechanisms.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01344APA
Granado, Miriam; Martín, Ana Isabel; López-Menduiña, María; López-Calderón, Asunción; Villanúa, M Angeles. (2008). GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.. American journal of physiology. Endocrinology and metabolism, 294(1), E131-41.
MLA
Granado, Miriam, et al. "GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.." American journal of physiology. Endocrinology and metabolism, 2008.
RethinkPeptides
RethinkPeptides Research Database. "GH-releasing peptide-2 administration prevents liver inflamm..." RPEP-01344. Retrieved from https://rethinkpeptides.com/research/granado-2008-ghreleasing-peptide2-administration-prevents
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.